Hong Kong Pharma Digital Technology Holdings Limited
HKPD
$1.35
-$0.09-6.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -16.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -16.85% | |||
| Cost of Revenue | 0.00% | -5.15% | |||
| Gross Profit | 0.00% | -73.26% | |||
| SG&A Expenses | 0.00% | 51.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | 1,325.00% | |||
| Total Operating Expenses | 0.00% | -0.08% | |||
| Operating Income | 0.00% | -181.45% | |||
| Income Before Tax | 0.00% | -196.32% | |||
| Income Tax Expenses | 0.00% | -157.98% | |||
| Earnings from Continuing Operations | 0.00% | -203.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -203.26% | |||
| EBIT | 0.00% | -181.45% | |||
| EBITDA | 0.00% | -174.89% | |||
| EPS Basic | 0.00% | -199.28% | |||
| Normalized Basic EPS | 0.00% | -187.58% | |||
| EPS Diluted | 0.00% | -199.76% | |||
| Normalized Diluted EPS | 0.00% | -187.58% | |||
| Average Basic Shares Outstanding | 0.00% | 4.11% | |||
| Average Diluted Shares Outstanding | 0.00% | 4.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||